Last reviewed · How we verify
NCT05431660
Diabetic Foot School and Biomechanics
NA trial testing education and exercise protocol about diabetic foot in Diabetic Foot in 50 participants. Status unknown.
1 July 2023
Quick facts
| Lead sponsor | Ankara Yildirim Beyazıt University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 50 |
| Start date | 1 September 2022 |
| Primary completion | 1 July 2023 |
| Estimated completion | 1 July 2024 |
Drugs / interventions tested
- education and exercise protocol about diabetic foot
- control group — full drug profile →
Conditions studied
- Diabetic Foot — all drugs for Diabetic Foot →
Sponsor
Ankara Yildirim Beyazıt University
Who can join
Adults 40 to 70, any sex, with Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aim of the study is to establish a diabetic foot school. The secondary aim is to compare the effects of the training given to diabetic foot patients within the scope of the diabetic foot school, on sensory, balance, lower extremity biomechanics and the effectiveness of these individuals on the knowledge level of diabetic foot. With the evaluations to be made, the effectiveness of the diabetic foot school program will be proven and it will contribute to the literature with objective and evidence-based results. For these reasons, the hypotheses on which the research is based were formed as follows; H11 hypothesis: The diabetic foot school program applied in diabetic foot patients has an effect on foot biomechanical measurements and gait parameters. Hypothesis H12: In diabetic foot patients, the diabetic foot school program has an effect on the sensation of individuals. H13 hypothesis: In diabetic foot patients, the diabetic foot school program has an effect on the balance of individuals. H14 hypothesis: In diabetic foot patients, the diabetic foot school program has an effect on the diabetic foot and self-care behaviors of individuals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05431660
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetic Foot
Currently open trials in the same condition.
- NCT06487780 — Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers · NA · recruiting
- NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
- NCT06760416 — Online Diabetic Foot Support Program- Care Kit · NA · active not recruiting
- NCT06552910 — Analyzing Anesthetic Techniques in Diabetic Foot Amputation · recruiting
- NCT06526936 — The Effect of Foot Care Training Given to Diabetic Hemodialysis Patients on Foot Care Behavior · NA · recruiting
Other Ankara Yildirim Beyazıt University trials
Trials by the same sponsor.
- NCT07530835 — Occlusal Changes After Modified Hall Technique in Molars Affected by Molar-Incisor Hypomineralization · NA · not yet recruiting
- NCT07496853 — Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke · NA · recruiting
- NCT07441668 — Comfort Intervention in PICU Children · NA · not yet recruiting
- NCT07431151 — Effects of Intensive Virtual Reality-Based Balance and Gait Training on Activity Performance and Quality of Life in Suba · NA · recruiting
- NCT07247903 — The Impact of Patient Education Delivered Through Virtual Reality · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05431660 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Yildirim Beyazıt University
- Last refreshed: 16 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05431660.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing